Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 32426-57-6
2. Lysergide D-tartrate
3. D-lsd 25 Bitartrate
4. 7wnp51ka7m
5. Lysergide Tartrate
6. Ergoline-8-beta-carboxamide, 9,10-didehydro-n,n-diethyl-6-methyl-, Tartrate (1:1), D-
7. (6ar,9r)-n,n-diethyl-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide;(2s,3s)-2,3-dihydroxybutanedioic Acid
8. (6ar,9r)-n,n-diethyl-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinoline-9-carboxamide;2,3-dihydroxybutanedioic Acid
9. D-9,10-didehydro-n,n-diethyl-6-methylergoline-8-beta-carboxamide Tartrate (1:1)
10. Unii-7wnp51ka7m
11. Lsd D-(-)-tartrate
12. Lsd (d-tartrate) (solution)
13. Akos040752817
14. Ls-64353
15. Lysergic Acid Diethylamide D-tartrate
16. D-lysergic Acid Diethylamide D-tartrate
17. Q27268952
18. Ergoline-8-carboxamide, 9,10-didehydro-n,n-diethyl-6-methyl-, (8.beta.)-, (2s,3s)-2,3-dihydroxybutanedioate (1:1)
19. Ergoline-8-carboxamide, 9,10-didehydro-n,n-diethyl-6-methyl-, (8.beta.)-, (s-(r*,r*))-2,3-dihydroxybutanedioate (1:1)
20. Ergoline-8.beta.-carboxamide, 9,10-didehydro-n,n-diethyl-6-methyl-, (-)-tartrate (1:1)
| Molecular Weight | 473.5 g/mol |
|---|---|
| Molecular Formula | C24H31N3O7 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 6 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 154 |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 661 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
92
PharmaCompass offers a list of Lysergide D-tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lysergide D-tartrate manufacturer or Lysergide D-tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lysergide D-tartrate manufacturer or Lysergide D-tartrate supplier.
PharmaCompass also assists you with knowing the Lysergide D-tartrate API Price utilized in the formulation of products. Lysergide D-tartrate API Price is not always fixed or binding as the Lysergide D-tartrate Price is obtained through a variety of data sources. The Lysergide D-tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lysergide D-tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lysergide D-tartrate, including repackagers and relabelers. The FDA regulates Lysergide D-tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lysergide D-tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lysergide D-tartrate supplier is an individual or a company that provides Lysergide D-tartrate active pharmaceutical ingredient (API) or Lysergide D-tartrate finished formulations upon request. The Lysergide D-tartrate suppliers may include Lysergide D-tartrate API manufacturers, exporters, distributors and traders.
Lysergide D-tartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lysergide D-tartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lysergide D-tartrate GMP manufacturer or Lysergide D-tartrate GMP API supplier for your needs.
A Lysergide D-tartrate CoA (Certificate of Analysis) is a formal document that attests to Lysergide D-tartrate's compliance with Lysergide D-tartrate specifications and serves as a tool for batch-level quality control.
Lysergide D-tartrate CoA mostly includes findings from lab analyses of a specific batch. For each Lysergide D-tartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lysergide D-tartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Lysergide D-tartrate EP), Lysergide D-tartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lysergide D-tartrate USP).
